Tenpoint Appoints Carol Kearney as Chief Commercial Officer for the Potential U.S. Launch of BRIMOCHOL™ PF
PRIVATEMar 12, 2025
Position
Chief Commercial Officer
Company
Tenpoint Therapeutics
Carol Kearney
SeattleBiotechnologyHealth CareTherapeutics
Description
Tenpoint Therapeutics Ltd. has announced the appointment of Carol Kearney as Chief Commercial Officer (CCO) to spearhead Tenpoint’s commercial strategy, including preparation of the potential U.S. launch of BRIMOCHOL™ PF, an investigational, preservative-free, once-daily eye drop designed to address the loss of near vision
Company Information
Company
Tenpoint Therapeutics
Location
Seattle, Washington, United States
About
Tenpoint is a biotechnology company committed to advancing engineered cell-based therapies and in vivo reprogramming to restore vision for people with degenerative ocular diseases, bringing together the global experts who are shaping the regenerative ocular medicine revolution and the technologies that are driving it. We are addressing the ultimate cause of vision loss by replacing diseased cells with healthy ones to permanently restore vision. Tenpoint’s global team is united by our passion for science and our commitment to patients.
Fundz sees it the moment Tenpoint Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
SeattleBiotechnologyHealth CareTherapeutics